Cancer Res Treat.  2019 Apr;51(2):417-430. 10.4143/crt.2019.138.

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016

• Jung KW
• Won YJ
• Kong HJ
• Lee ES
• The Community of Population-Based Regional Cancer Registries

• KMID: 2464389
• DOI: http://doi.org/10.4143/crt.2019.138

Abstract

PURPOSE
This study presents the 2016 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality.
MATERIALS AND METHODS
Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database and followed until December 31, 2017. Mortality data from 1983 to 2016 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality, and prevalence and 5-year relative survivals were also calculated.
RESULTS
Overall, 229,180 and 78,194 Koreans were newly diagnosed and died from cancer in 2016, respectively. The ASRs for cancer incidence and mortality in 2016 were 269.0 and 79.8 per 100,000 individuals, respectively. The all-cancer incidence rate increased significantly by 3.6% annually from 1999 to 2011 and started to decrease after 2011 (2011-2016; annual percent change, -3.1%). However, overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2012 and 2016 was 70.6%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995.
CONCLUSION
The cancer prevalence in Korea has increased very fast as survival has improved remarkably. The high prevalence of cancer emphasizes the need for comprehensive cancer control efforts in Korea.

Keyword

Incidence; Survival; Prevalence; Mortality; Neoplasms; Korea

MeSH Terms

Humans
Incidence*
Korea*
Mortality*
Prevalence*
Survival Rate

Figure

• 

  Fig. 1. Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2016 in Korea. Age standardization was based on the Segi’s world standard population.

• 

  Fig. 2. Trends in age-standardized incidences of selected cancers by sex from 1999 to 2016 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.

• 

  Fig. 3. Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2016 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.

• 

  Fig. 4. Age-specific incidence rates of common cancers for 2016 in Korea. (A) Men. (B) Women.

• 

  Fig. 5. Trends in relative survival by year of diagnosis from 1999 to 2016. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.

• 

  Fig. 6. Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed between 1999 and 2016.

Reference

References

1. Global cancer observatory [Internet]. Lyon: International Agency for Research on Cancer;2018. [cited 2019 Jan 23]. Available from: https://gco.iarc.fr/.

2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.

3. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registires. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018; 50:303–16.

4. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee JK, et al. Prediction of cancer incidence and mortality in Korea, 2016. Cancer Res Treat. 2016; 48:451–7.

5. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–31.

6. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998; 45:1011–7.

7. Statistics Korea [Internet]. Daejeon: Statistics Korea;2017. [cited 2019 Feb 15]. Available from: http://kosis.kr.

8. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st revision. Geneva: World Health Organization;2013.

9. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. ed. Geneva: World Health Organization;1994.

10. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2013 [Internet]. Bethesda, MD: National Cancer Institute;2016. [cited 2017 Feb 20]. Available from: http://seer.cancer.gov/csr/1975_2013/.

11. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine;1960.

12. Day NE. Cumulative rates and cumulative risk. In : Muir C, Waterhouse J, Mack T, Powell J, Whelan S, editors. Cancer incidence in five continents, Vol. V. IARC Scientific Publications No. 88. Lyon: International Agency for Research on Cancer;1987. p. 787–9.

13. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10. Bethesda, MD: National Cancer Institute;1959.

14. Paul Dickman [Internet]. Stockholm: PaulDickman.com;2016. [cited 2019 Feb 15]. Available from: http://www.pauldickman.com.